Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $81.0200 (-0.93%) ($80.4100 - $81.7200) on Fri. Jan. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.17% (three month average) | RSI | 15 | Latest Price | $81.0200(-0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(52%) | Factors Impacting ABBV price | ABBV will decline at least -0.585% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) IGOV(-5%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.585% (StdDev 1.17%) | Hourly BBV | -0.8 () | Intraday Trend | -0.5% | | | |
|
1 - 5 Day Possible Target | $77.68(-4.12%) | Resistance Level | $86.68 | 5 Day Moving Average | $82.76(-2.1%) | 10 Day Moving Average | $84.44(-4.05%) | 20 Day Moving Average | $86.68(-6.53%) | To recent high | -10.2% | To recent low | 1.8% | Market Cap | $142.942b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |